{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:03:10Z","timestamp":1784181790852,"version":"3.55.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijtb.2025.12.001","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:56:40Z","timestamp":1765814200000},"page":"394-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nontuberculous Mycobacteria: An update"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-2417","authenticated-orcid":false,"given":"Prasanta Raghab","family":"Mohapatra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baijayantimala","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijtb.2025.12.001_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccm.2014.10.003","article-title":"3rd. Environmental sources of nontuberculous mycobacteria","volume":"36","author":"Falkinham","year":"2015","journal-title":"Clin Chest Med"},{"issue":"8","key":"10.1016\/j.ijtb.2025.12.001_bib2","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s40121-024-01015-z","article-title":"Real-world patients' Diagnosis-to-Treatment journey with nontuberculous mycobacterial pulmonary disease: a cross-sectional survey","volume":"13","author":"Morimoto","year":"2024","journal-title":"Infect Dis Ther"},{"issue":"5","key":"10.1016\/j.ijtb.2025.12.001_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01640-23","article-title":"Treatment outcomes and relapse in patients with mycobacterium avium-intracellulare complex pulmonary disease","volume":"11","author":"Chang","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"4","key":"10.1016\/j.ijtb.2025.12.001_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ccm.2023.08.012","article-title":"Global epidemiology of nontuberculous mycobacterial pulmonary disease: a review","volume":"44","author":"Prevots","year":"2023","journal-title":"Clin Chest Med"},{"issue":"1","key":"10.1016\/j.ijtb.2025.12.001_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00250-2019","article-title":"Non-tuberculous mycobacterial pulmonary disease","volume":"54","author":"Cowman","year":"2019","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ijtb.2025.12.001_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3201\/eid2403.171301","article-title":"Increasing prevalence of nontuberculous mycobacteria in respiratory specimens from US-Affiliated Pacific Island Jurisdictions(1)","volume":"24","author":"Lin","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2025.12.001_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12879-018-3113-x","article-title":"High mortality in patients with Mycobacterium avium complex lung disease: a systematic review","volume":"18","author":"Diel","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.ijtb.2025.12.001_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055672","article-title":"Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006-2021: a systematic review and meta-analysis","volume":"12","author":"Zhou","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijtb.2024.08.006","article-title":"Epidemiology of nontuberculous mycobacteria infection in Asia: a narrative review","volume":"72","author":"Ong","year":"2025","journal-title":"Indian J Tuberc"},{"issue":"Abstracts","key":"10.1016\/j.ijtb.2025.12.001_bib10","article-title":"Prevalence and geographical distribution of various nontuberculous mycobacterial (NTM) species\/subspecies in India: early findings of Indian council of medical research (ICMR), New Delhi sponsored multicentre research project between 2021-2024","volume":"211","author":"Sharma","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ijtb.2025.12.001_bib11","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid2206.151086","article-title":"Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan","volume":"22","author":"Namkoong","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.ijtb.2025.12.001_bib12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an Official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijtb.2025.12.001_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151682","article-title":"High mortality of disseminated non-tuberculous mycobacterial infection in HIV-infected patients in the antiretroviral therapy era","volume":"11","author":"Kobayashi","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib14","article-title":"Factors associated with treatment outcome in patients with nontuberculous mycobacterial pulmonary disease: a large population-based retrospective cohort study in Shanghai","volume":"7","author":"Cheng","year":"2022","journal-title":"Trop Med Infect Dis"},{"issue":"5","key":"10.1016\/j.ijtb.2025.12.001_bib15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1128\/JCM.03556-14","article-title":"Molecular identification of Mycobacterium avium subsp. silvaticum by duplex high-resolution melt analysis and subspecies-specific real-time PCR","volume":"53","author":"R\u00f3nai","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ijtb.2025.12.001_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3201\/eid1703.101510","article-title":"Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease","volume":"17","author":"Falkinham","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijtb.2025.12.001_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fmed.2017.00027","article-title":"Infection sources of a common non-tuberculous mycobacterial pathogen, Mycobacterium avium complex","volume":"4","author":"Nishiuchi","year":"2017","journal-title":"Front Med"},{"issue":"6","key":"10.1016\/j.ijtb.2025.12.001_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1164\/rccm.201205-0913OC","article-title":"Spatial clusters of nontuberculous mycobacterial lung disease in the United States","volume":"186","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"6313","key":"10.1016\/j.ijtb.2025.12.001_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1126\/science.aaf8156","article-title":"Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium","volume":"354","author":"Bryant","year":"2016","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ijtb.2025.12.001_bib20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1513\/AnnalsATS.201412-559OC","article-title":"Population-based incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012","volume":"12","author":"Henkle","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.ijtb.2025.12.001_bib21","doi-asserted-by":"crossref","first-page":"ofaa173","DOI":"10.1093\/ofid\/ofaa173","article-title":"Characteristics of nontuberculous mycobacterial infections at a midwestern tertiary hospital: a retrospective study of 365 patients","volume":"7","author":"Hannah","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2025.12.001_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12890-022-02075-y","article-title":"Comorbidities of nontuberculous mycobacteria infection in Korean adults: results from the national health insurance service-national sample cohort (NHIS-NSC) database","volume":"22","author":"Lee","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1513\/AnnalsATS.201804-236OC","article-title":"Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008-2015","volume":"17","author":"Winthrop","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.ijtb.2025.12.001_bib24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.chest.2021.10.003","article-title":"Nontuberculous mycobacterial pulmonary disease: clinical epidemiologic features, risk factors, and diagnosis: the nontuberculous mycobacterial series","volume":"161","author":"Kumar","year":"2022","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijtb.2025.12.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinme.2024.100016","article-title":"Extrapulmonary nontuberculous mycobacterial infections: a guide for the general physician","volume":"24","author":"Malhotra","year":"2024","journal-title":"Clin Med"},{"issue":"3","key":"10.1016\/j.ijtb.2025.12.001_bib26","article-title":"Clinical characteristics of nontuberculous mycobacterial positivity occurring during multidrug-resistant tuberculosis treatment: a retrospective study","volume":"10","author":"Wang","year":"2025","journal-title":"Trop Med Infect Dis"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/ijmy.ijmy_68_22","article-title":"Clinical presentations of nontuberculous mycobacteria as suspected and drug-resistant tuberculosis: experience from a tertiary care center in Eastern India","volume":"11","author":"Das","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.ijtb.2025.12.001_bib28","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.ijid.2020.02.022","article-title":"Non-tuberculous mycobacterial infections-A neglected and emerging problem","volume":"92s","author":"Ahmed","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1378\/chest.75.2.115","article-title":"Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases","volume":"75","author":"Rosenzweig","year":"1979","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2019.114916","article-title":"'Lady Windermere's counterpart? Pulmonary nontuberculous mycobacteria in men with bronchiectasis","volume":"96","author":"Ku","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.ijtb.2025.12.001_bib31","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.21037\/jtd-23-1648","article-title":"Mycobacterium gordonae: the canary in the coal mine?","volume":"16","author":"Condit","year":"2024","journal-title":"J Thorac Dis"},{"issue":"7","key":"10.1016\/j.ijtb.2025.12.001_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02316-24","article-title":"Simultaneous detection and differentiation of Mycobacterium tuberculosis and nontuberculous mycobacteria in smear-negative sputum by a multiplex PCR assay: a clinical feasibility study","volume":"13","author":"Xie","year":"2025","journal-title":"Microbiol Spectr"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3343\/alm.2020.40.2.169","article-title":"Diagnostic performance of the GENEDIA MTB\/NTM detection kit for detecting Mycobacterium tuberculosis and nontuberculous mycobacteria with sputum specimens","volume":"40","author":"Shin","year":"2020","journal-title":"Ann Lab Med"},{"issue":"14","key":"10.1016\/j.ijtb.2025.12.001_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15141776","article-title":"Diagnostic accuracy of AdvanSure(TM) and PowerChek(TM) real-time PCR assays for the detection of Mycobacterium tuberculosis and nontuberculous mycobacteria","volume":"15","author":"Bajgai","year":"2025","journal-title":"Diagnostics"},{"issue":"6","key":"10.1016\/j.ijtb.2025.12.001_bib35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cmi.2017.11.012","article-title":"How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry","volume":"24","author":"Alcaide","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ijtb.2025.12.001_bib36","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/s41598-022-05315-7","article-title":"Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification","volume":"12","author":"Rodriguez-Temporal","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ijtb.2025.12.001_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10123-020-00143-z","article-title":"Detection of Mycobacterium kansasii using a combination of loop-mediated isothermal amplification (LAMP) and lateral flow biosensors","volume":"24","author":"Chen","year":"2021","journal-title":"Int Microbiol"},{"key":"10.1016\/j.ijtb.2025.12.001_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2025.107226","article-title":"Revolutionizing non-tuberculous mycobacteria research: advances in molecular diagnostics, phylogenetics, and clinical management","volume":"237","author":"Saminathan","year":"2025","journal-title":"J Microbiol Methods"},{"issue":"4","key":"10.1016\/j.ijtb.2025.12.001_bib39","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.meegid.2011.10.006","article-title":"Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?","volume":"12","author":"van Ingen","year":"2012","journal-title":"Infect Genet Evol"},{"issue":"Suppl 2","key":"10.1016\/j.ijtb.2025.12.001_bib40","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British Thoracic society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2025.12.001_bib41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijid.2020.02.059","article-title":"Comparative analysis of phenotypic and genotypic antibiotic susceptibility patterns in Mycobacterium avium complex","volume":"93","author":"Wetzstein","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijtb.2025.12.001_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fcimb.2020.00449","article-title":"Comprehensive determination of Mycobacterium tuberculosis and nontuberculous mycobacteria from targeted capture sequencing","volume":"10","author":"He","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"10.1016\/j.ijtb.2025.12.001_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01547-19","article-title":"Antimicrobial treatment provides a competitive advantage to Mycobacterium abscessus in a dual-species biofilm with Pseudomonas aeruginosa","volume":"63","author":"Rodr\u00edguez-Sevilla","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ijtb.2025.12.001_bib44","first-page":"217","article-title":"Host defense against nontuberculous mycobacterial infections","volume":"11","author":"Holland","year":"1996","journal-title":"Semin Respir Infect"},{"issue":"3","key":"10.1016\/j.ijtb.2025.12.001_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/RTI.0000000000000610","article-title":"Chest computed tomography features of nontuberculous mycobacterial pulmonary disease versus asymptomatic colonization: a cross-sectional cohort study","volume":"37","author":"Garcia","year":"2022","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.ijtb.2025.12.001_bib46","first-page":"6","article-title":"Inflammation: a two-edged sword--the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"issue":"Suppl 2","key":"10.1016\/j.ijtb.2025.12.001_bib47","first-page":"A238","article-title":"M8 non-tuberculous mycobacteria testing in bronchiectasis in the UK: data from the EMBARC registry","volume":"74","author":"Finch","year":"2019","journal-title":"Thorax"},{"issue":"45","key":"10.1016\/j.ijtb.2025.12.001_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017869","article-title":"Incidence, comorbidities, and treatment patterns of nontuberculous mycobacterial infection in South Korea","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.ijtb.2025.12.001_bib49","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00097-2019","article-title":"Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease","volume":"6","author":"Izumi","year":"2020","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.ijtb.2025.12.001_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70060","article-title":"Prevalence of chronic pulmonary aspergillosis in patients with mycobacterial and non-mycobacterial tuberculosis infection of the lung: a systematic review and meta-analysis","volume":"68","author":"Sehgal","year":"2025","journal-title":"Mycoses"},{"issue":"11","key":"10.1016\/j.ijtb.2025.12.001_bib51","doi-asserted-by":"crossref","first-page":"797","DOI":"10.5588\/ijtld.23.0215","article-title":"Concomitant or sequential pulmonary infection with non-tuberculous mycobacteria and aspergillus","volume":"27","author":"Kumar","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2025.12.001_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jinf.2023.04.009","article-title":"Management of nontuberculous mycobacteria-pulmonary disease: results from the first UK survey of clinical practice","volume":"87","author":"Malhotra","year":"2023","journal-title":"J Infect"},{"issue":"Suppl 1","key":"10.1016\/j.ijtb.2025.12.001_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British thoracic society guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1378\/chest.13-2538","article-title":"Macrolide\/Azalide therapy for nodular\/bronchiectatic mycobacterium avium complex lung disease","volume":"146","author":"Wallace","year":"2014","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ijtb.2025.12.001_bib55","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/AAC.04577-14","article-title":"Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease","volume":"59","author":"Lee","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijtb.2025.12.001_bib56","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02503-2016","article-title":"Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype","volume":"50","author":"Koh","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ijtb.2025.12.001_bib57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jamp.2017.1443","article-title":"Impact of hypertonic saline solutions on sputum expectoration and their safety profile in patients with bronchiectasis: a randomized crossover trial","volume":"31","author":"Herrero-Cortina","year":"2018","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"12","key":"10.1016\/j.ijtb.2025.12.001_bib58","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.ajem.2020.08.042","article-title":"The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies","volume":"38","author":"Xie","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"5","key":"10.1016\/j.ijtb.2025.12.001_bib59","first-page":"1","article-title":"The influencing factors of extensive lung lesions and cavities in patients with non-tuberculous mycobacterial lung disease","volume":"86","author":"Li","year":"2025","journal-title":"Br J Hosp Med"},{"issue":"Suppl 1","key":"10.1016\/j.ijtb.2025.12.001_bib60","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.ijid.2021.03.064","article-title":"Non tuberculous mycobacteria pulmonary disease: patients and clinicians working together to improve the evidence base for care","volume":"113","author":"Lipman","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.ijtb.2025.12.001_bib61","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/17476348.2021.1887734","article-title":"A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective","volume":"15","author":"Ali","year":"2021","journal-title":"Expert Rev Respir Med"},{"issue":"5","key":"10.1016\/j.ijtb.2025.12.001_bib62","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.chest.2021.10.048","article-title":"Impact of time between diagnosis and treatment for nontuberculous mycobacterial pulmonary disease on culture conversion and all-cause mortality","volume":"161","author":"Im","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.ijtb.2025.12.001_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2019.03.014","article-title":"Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease","volume":"151","author":"Moon","year":"2019","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.ijtb.2025.12.001_bib64","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00537-2016","article-title":"Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course","volume":"49","author":"Hwang","year":"2017","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.ijtb.2025.12.001_bib65","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02261-21","article-title":"Treatment outcomes of cavitary nodular bronchiectatic-type Mycobacterium avium complex pulmonary disease","volume":"66","author":"Chae","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijtb.2025.12.001_bib66","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00798-2019","article-title":"Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study","volume":"55","author":"Jhun","year":"2020","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ijtb.2025.12.001_bib67","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02210-2023","article-title":"Rifampicin has no role in treatment of Mycobacterium avium complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpoint","volume":"63","author":"van Ingen","year":"2024","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.ijtb.2025.12.001_bib68","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/jac\/dkr209","article-title":"Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus","volume":"66","author":"Nessar","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.ijtb.2025.12.001_bib69","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00011-18","article-title":"Amikacin inhalation as salvage therapy for refractory nontuberculous mycobacterial lung disease","volume":"62","author":"Jhun","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijtb.2025.12.001_bib70","series-title":"A16 NTM WITH A SIDE OF BRONCHIECTASIS","article-title":"Microbiologic outcomes from a randomized, double-blind trial of amikacin liposome inhalation suspension in adults with newly diagnosed or recurrent Mycobacterium avium complex lung disease: the ARISE study","author":"Daley","year":"2024"},{"issue":"10","key":"10.1016\/j.ijtb.2025.12.001_bib71","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JCM.01612-13","article-title":"In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates","volume":"51","author":"Brown-Elliott","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"15","key":"10.1016\/j.ijtb.2025.12.001_bib72","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1080\/14656566.2021.1953472","article-title":"The role of amikacin in the treatment of nontuberculous mycobacterial disease","volume":"22","author":"Raaijmakers","year":"2021","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib73","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01798-16","article-title":"In vitro susceptibility testing of bedaquiline against Mycobacterium avium complex","volume":"61","author":"Brown-Elliott","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib74","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1378\/chest.14-2764","article-title":"Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease","volume":"148","author":"Philley","year":"2015","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijtb.2025.12.001_bib75","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00118-2019","article-title":"Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease","volume":"54","author":"Zweijpfenning","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ijtb.2025.12.001_bib76","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jiac.2017.10.022","article-title":"Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens","volume":"24","author":"Cho","year":"2018","journal-title":"J Infect Chemother"},{"issue":"suppl_2","key":"10.1016\/j.ijtb.2025.12.001_bib77","doi-asserted-by":"crossref","first-page":"i24","DOI":"10.1093\/jac\/dkx304","article-title":"Linezolid as treatment for pulmonary Mycobacterium avium disease","volume":"72","author":"Deshpande","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.ijtb.2025.12.001_bib78","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1164\/ajrccm.165.2.2107025","article-title":"Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs","volume":"165","author":"Goldstein","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ijtb.2025.12.001_bib80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14787210.2020.1720650","article-title":"Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis","volume":"18","author":"Nasiri","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib81","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1128\/AAC.00861-10","article-title":"Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing","volume":"55","author":"Bastian","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijtb.2025.12.001_bib82","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1348-0421.2010.00221.x","article-title":"Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns","volume":"54","author":"Kim","year":"2010","journal-title":"Microbiol Immunol"},{"issue":"4","key":"10.1016\/j.ijtb.2025.12.001_bib83","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/cid\/ciz1014","article-title":"Omadacycline in the treatment of Mycobacterium abscessus infection","volume":"71","author":"Madariaga","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ijtb.2025.12.001_bib84","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/jac\/dkz267","article-title":"Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus","volume":"74","author":"Bax","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.ijtb.2025.12.001_bib85","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"Wallace","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijtb.2025.12.001_bib86","series-title":"Lung Nontuberculous Mycobacterial Infections. Statpearls. Treasure Island (FL): Statpearls Publishing Copyright \u00a9 2024","author":"Bethencourt Mirabal","year":"2024"},{"issue":"12","key":"10.1016\/j.ijtb.2025.12.001_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9122527","article-title":"Mycobacterium abscessus genetic determinants associated with the intrinsic resistance to antibiotics","volume":"9","author":"Gorzynski","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijtb.2025.12.001_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.659997","article-title":"Mycobacterium abscessus complex: a review of recent developments in an emerging pathogen","volume":"11","author":"Victoria","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.ijtb.2025.12.001_bib89","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1183\/20734735.027218","article-title":"Surgery in nontuberculous mycobacteria pulmonary disease","volume":"14","author":"Lu","year":"2018","journal-title":"Breathe"},{"key":"10.1016\/j.ijtb.2025.12.001_bib90","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12879-015-0823-1","article-title":"Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease","volume":"15","author":"Kang","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.ijtb.2025.12.001_bib91","first-page":"671","article-title":"Lady windermere revisited: treatment with thoracoscopic lobectomy\/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease","volume":"40","author":"Yu","year":"2011","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib92","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.athoracsur.2004.02.103","article-title":"Pneumonectomy for nontuberculous mycobacterial infections","volume":"78","author":"Shiraishi","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.ijtb.2025.12.001_bib93","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/S1473-3099(21)00586-7","article-title":"Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases","volume":"22","author":"Lange","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.ijtb.2025.12.001_bib94","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijantimicag.2009.09.023","article-title":"In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in the Netherlands","volume":"35","author":"van Ingen","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.ijtb.2025.12.001_bib95","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02331-18","article-title":"Species distribution and macrolide susceptibility of Mycobacterium fortuitum complex clinical isolates","volume":"63","author":"Kim","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijtb.2025.12.001_bib96","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.rmed.2007.10.005","article-title":"Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens","volume":"102","author":"Park","year":"2008","journal-title":"Respir Med"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570725002720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570725002720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:03:56Z","timestamp":1784178236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570725002720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0019570725002720"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2025.12.001","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nontuberculous Mycobacteria: An update","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2025.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Tuberculosis Association of India. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}